Great West Life Assurance Co. Can bought a new stake in Balchem Co. (NASDAQ:BCPC – Get Rating) during the third quarter, HoldingsChannel.com reports. The institutional investor bought 39,257 shares of the basic materials company’s stock, valued at approximately $4,779,000.
A number of other institutional investors have also modified their holdings of the stock. BlackRock Inc. increased its holdings in shares of Balchem by 1.0% in the first quarter. BlackRock Inc. now owns 4,890,972 shares of the basic materials company’s stock valued at $668,595,000 after purchasing an additional 46,959 shares during the period. State Street Corp grew its holdings in Balchem by 0.4% during the second quarter. State Street Corp now owns 1,050,282 shares of the basic materials company’s stock worth $136,264,000 after acquiring an additional 3,778 shares during the period. Conestoga Capital Advisors LLC grew its holdings in Balchem by 2.6% during the third quarter. Conestoga Capital Advisors LLC now owns 1,033,516 shares of the basic materials company’s stock worth $125,655,000 after acquiring an additional 26,163 shares during the period. Geneva Capital Management LLC grew its holdings in Balchem by 7.4% during the second quarter. Geneva Capital Management LLC now owns 696,285 shares of the basic materials company’s stock worth $90,336,000 after acquiring an additional 48,041 shares during the period. Finally, Clearbridge Investments LLC grew its holdings in Balchem by 0.3% during the first quarter. Clearbridge Investments LLC now owns 503,403 shares of the basic materials company’s stock worth $68,815,000 after acquiring an additional 1,409 shares during the period. Institutional investors and hedge funds own 89.29% of the company’s stock.
Balchem Stock Up 1.3 %
BCPC opened at $125.72 on Monday. The business’s fifty day moving average is $130.09 and its two-hundred day moving average is $130.48. The company has a debt-to-equity ratio of 0.54, a quick ratio of 1.61 and a current ratio of 2.59. The company has a market cap of $4.04 billion, a price-to-earnings ratio of 37.53 and a beta of 0.67. Balchem Co. has a one year low of $110.15 and a one year high of $151.71.
Balchem Increases Dividend
The company also recently announced an annual dividend, which was paid on Friday, January 20th. Shareholders of record on Tuesday, December 27th were given a dividend of $0.71 per share. This represents a yield of 0.53%. This is an increase from Balchem’s previous annual dividend of $0.64. The ex-dividend date of this dividend was Friday, December 23rd. Balchem’s payout ratio is presently 21.19%.
Analyst Upgrades and Downgrades
A number of research analysts recently weighed in on BCPC shares. HC Wainwright dropped their price objective on Balchem from $164.00 to $152.00 and set a “buy” rating on the stock in a report on Monday, November 7th. StockNews.com started coverage on Balchem in a report on Wednesday, October 12th. They set a “hold” rating on the stock.
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
- Get a free copy of the StockNews.com research report on Balchem (BCPC)
- CVS Health is Growing into an Integrated Healthcare Organization
- Is C3.ai Stock a ChatGPT Artificial Intelligence Play?
- NVIDIA Outlook Improving: Watchlist Candidate for 2023
- Which Wireless Stock Should You Buy in 2023?
- Is Virgin Galactic Stock Preparing for Lift-Off?
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.